Isonicotinoylhydrazothiazoles and isonicotinoyl-N4-substituted thiosemicarbazides : Synthesis, characterization, and anti-mycobacterial activity

Differently substituted isonicotinoylhydrazothiazoles and isonicotinoyl-N4-substituted thiosemi-carbazides have been prepared and characterized by means of elemental analysis, 1H-NMR, 13C-NMR, and Mass spectrometry. All the synthesised compounds have been screened in order to evaluate their antimycobacterial activity in vitro. Some of the new compounds showed activity towards M. tuberculosis H37R and M. Marinum in the millimolar range.

[1]  E. Maccioni,et al.  Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. , 2004, Farmaco.

[2]  E. Maccioni,et al.  Synthesis and Biological Activity Evaluation of Differently Substituted 1,4‐Dioxo‐3,4‐dihydrophthalazine‐2(1H)‐carboxamides and ‐carbothioamides. , 2003 .

[3]  E. Banfi,et al.  Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives. , 2003, Farmaco.

[4]  E. Maccioni,et al.  Synthesis of new arylidencycloalkylpyrazoles of potential biological interest , 2003 .

[5]  Clifton E. Barry,et al.  Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I , 2002, Journal of bacteriology.

[6]  V. Onnis,et al.  Synthesis and antimycobacterial activity of new S-alkylisothiosemicarbazone derivatives. , 2002, Bioorganic & medicinal chemistry.

[7]  S. Rollas,,et al.  Synthesis and structure elucidation of some new thioether derivatives of 1,2,4-triazoline-3-thiones and their antimicrobial activities. , 2001, Farmaco.

[8]  E. Maccioni,et al.  Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones. , 2001, Farmaco.

[9]  C. Townsend,et al.  In Vitro Activity of a Novel Antimycobacterial Compound, N-Octanesulfonylacetamide, and Its Effects on Lipid and Mycolic Acid Synthesis , 2001, Antimicrobial Agents and Chemotherapy.

[10]  James C. Sacchettini,et al.  Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis , 2000, Journal of bacteriology.

[11]  Clifton E. Barry,et al.  A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis , 2000, Nature.

[12]  M. Cynamon,et al.  Activities of Several Novel Oxazolidinones againstMycobacterium tuberculosis in a Murine Model , 1999, Antimicrobial Agents and Chemotherapy.

[13]  J. D. Douglas,et al.  Antimycobacterial Activities of Isoxyl and New Derivatives through the Inhibition of Mycolic Acid Synthesis , 1999, Antimicrobial Agents and Chemotherapy.

[14]  P. Gangadharam,et al.  Antimycobacterial activities of riminophenazines. , 1999, The Journal of antimicrobial chemotherapy.

[15]  Rossella Fioravanti,et al.  Bactericidal Activities of the Pyrrole Derivative BM212 against Multidrug-Resistant and Intramacrophagic Mycobacterium tuberculosis Strains , 1998, Antimicrobial Agents and Chemotherapy.

[16]  R. Conradi,et al.  Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. , 1998, Journal of medicinal chemistry.

[17]  G. Besra,et al.  Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis , 1996, Antimicrobial agents and chemotherapy.

[18]  M. Cynamon,et al.  Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. , 1996, Journal of medicinal chemistry.

[19]  K. Suzuki,et al.  In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis , 1996, Antimicrobial agents and chemotherapy.

[20]  N. Mahfouz,et al.  Design, synthesis and antiinflammatory activity of some 1,3,4-oxadiazole derivatives. , 1997, European journal of medicinal chemistry.

[21]  P. Schultz,et al.  Mechanistic Studies of the Oxidation of Isoniazid by the Catalase Peroxidase from Mycobacterium tuberculosis , 1994 .

[22]  V. Hariprasad,et al.  Anti-inflammatory activity of substituted 1,3,4-oxadiazoles. , 1994, Journal of pharmaceutical sciences.

[23]  W. Jacobs,et al.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.

[24]  H. Tomioka,et al.  In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins , 1991, Antimicrobial Agents and Chemotherapy.

[25]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[26]  I. Mir,et al.  Antituberculosis agents. I. Alpha-(5-(2-Furyl)-1,2,4-triazol-3-ylthio) acethydrazide and related compounds. , 1970, Tetrahedron.

[27]  John Lee,et al.  THE SYNTHESIS OF COMPOUNDS FOR THE CHEMOTHERAPY OF TUBERCULOSIS. IV. THE AMIDE FUNCTION1 , 1954 .

[28]  J. H. Williams,et al.  Experimental Chemotherapy of Tuberculosis. II. The Synthesis of Pyrazinamides and Related Compounds1 , 1952 .